Friday, 15 Dec 2017

You are here

RheumNow Week in Review - 19 May 2016

Dr. Jack Cush reviews this week's news and research highlights from RheumNow.com.

  1. RCT shows 12 wks of PT vs TaiChi was equally effective in Knee OA looking at 52 week outcomes, including WOMAC scores. But less depression and better QOL measures seen in the Tai Chi group https://t.co/ntDUo5rxX8
  2. Lupus retinopathy seen in 12% of 96 lupus patients; mild in 61%. Those with retinopathy had higher serum Creatinine, ESR, & Platelet counts https://t.co/wPSaxmpWak
  3. The prevalence of Gout in NIDDM is ~10%; Patients with both Gout and NIDDM are  likely to be elderly, men, obese, with high lipids, neuropathy and lower GFR. https://t.co/FWnneUXn11
  4. Cohort study shows that some kids with systemic JIA will respond to NSAIDs alone.  Those most likely to be NSAID responsive are < 6 yrs, have 5 or less joints and CRP < 1.3mg/dl  https://t.co/WDX8cI834g
  5. Analysis of 17 patients with Multicentric Reticulonodular histiocytosis shows good responses with TNF inhibitors (+/- DMARD)  https://t.co/itsBYZULZq
  6. Reviews of 21 major US & UK newspapers finds social embarrassment seen with gout in 24% of articles and jokes or humor to gout in 26%. https://t.co/HANZqmMyUP
  7. Reports Call for More Gout Education as surveys show patients to be unclear about their condition, often undertreated, improperly monitored and frequently stigmatized by their gout.  
  8. Risk Factors for Bisphosphonate Bone Complications.   

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

The RheumNow Week in Review - 8 December 2017

Dr. Jack Cush covers the news and journal articles published on RheumNow.comin the past week.

Rheumatology Year in Review

During 2017, the improvements and refinements seen during previous years in the treatment of rheumatoid arthritis have been extending to other conditions ranging from psoriatic arthritis to lupus and for both monoclonal antibodies and oral small molecule medications.

Advances for Biologics

The ACR17 RheumNow Week in Review - 1 December 2017

Dr Jack Cush reviews nighlights and news from the past 2 weeks on RheumNow.com. This week's report includes new drug approvals, disappointing ACR guidelines, Lyme & Zika, infertility, dermatomyositis skin outcomes and myositis-associated cancer testing.

ACR Clinical Guidelines Flawed by Low Evidence

JAMA Internal Medicine has reported that recommendations and clinical practice guidelines from the American College of Rheumatology are often based on expert opinion, but lack rigorous (grade A) evidence to support many of their recommendations. 

RheumNow ACR 2017 Awards

The Annual Meeting of the American College of Rheumatology is a gargantuan educational and professional event that is on nearly everyone's radar each year. RheumNow had an expansive effort to cover this meeting and you can review the work of our faculty at ACR17.RheumNow.com.  But we have decided to take this one step further and today we are announcing our 2017 RheumNow ACR Awards.